Adverse reactions to weight-loss jabs are set to soar by more than 350% in a single year, according to the latest data.

The biosimilars segment, too, will see fresh launches including Bevacizumab in the US, and Semaglutide filings across developed and emerging markets, including India by calendar 2026.

According to a new major clinical trial known as the ESSENCE trial, semaglutide—better known as Ozempic when used for Type 2 ...

Hims & Hers achieved 136% YoY subscriber growth and unveiled ambitious 2030 goals. Discover how precision medicine drives ...

Following a similar decision in case the trade group Outsourcing Facilities Association brought against FDA over its decision ...

Against increasing use of weight loss jabs, Weight Watchers has filed for bankruptcy. Writer Daisy Buchanan reflects on her ...

Ozempic is hailed as a miracle drug by some people using it to lose weight, however, it isn't suitable for everyone and can ...

Ozempic, Wegovy and Mounjaro can still be expensive, but pharmacy produced GLP-1 compounds are becoming much more affordable.

The metabolic effects of weight management medicines extend beyond appetite regulation. Still, with more questions about ...

Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 -- --Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

We expected miracles; what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...